| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $12.1M | +25.2% |
| Cost of Revenue | $3.7M | -11.7% |
| Gross Profit | $8.4M | +53.6% |
| R&D Expense | $2.6M | -20.4% |
| SG&A Expense | $14.6M | -17.1% |
| Operating Income | -$8.8M | +42.7% |
| Interest Expense | $3.0M | +64.1% |
| Pre-tax Income | -$14.1M | +24.5% |
| Net Income | -$14.1M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $786K | +37.8% |
| Accounts Receivable | $1.5M | +20.0% |
| Inventory | $1.9M | -19.6% |
| Current Assets | $4.5M | -5.3% |
| Total Assets | $5.9M | -8.7% |
| Current Liabilities | $22.7M | +103.4% |
| Total Liabilities | $35.9M | +36.3% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | +50.6% |
| Financing Cash Flow | $6.7M | +236.8% |
| +24.5% |
| EPS (Basic) | -$1.66 | -341.5% |
| EPS (Diluted) | -$1.66 | +26.4% |
| Stockholders' Equity |
| -$31.5M |
| -58.6% |